BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8129257)

  • 1. The "Telefono Rosso": a service for the prevention of birth defects and for the evaluation of teratogenic risk.
    Mastroiacovo P; Serafini M; Pagano M; De Santis M; Vercillo I; Celestini E
    Ann Ist Super Sanita; 1993; 29(1):115-20. PubMed ID: 8129257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconceptional counseling.
    Taysi K
    Obstet Gynecol Clin North Am; 1988 Jun; 15(2):167-78. PubMed ID: 3226663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.
    Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P
    Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study.
    De Santis M; Cavaliere AF; Straface G; Carducci B; Caruso A
    Fertil Steril; 2005 Aug; 84(2):296-9. PubMed ID: 16084867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing surveillance for human teratogenicity: a model approach.
    Chambers CD; Braddock SR; Briggs GG; Einarson A; Johnson YR; Miller RK; Polifka JE; Robinson LK; Stepanuk K; Lyons Jones K
    Teratology; 2001 Nov; 64(5):252-61. PubMed ID: 11745831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced abortion: not an independent risk factor for pregnancy outcome, but a challenge for health counseling.
    Raatikainen K; Heiskanen N; Heinonen S
    Ann Epidemiol; 2006 Aug; 16(8):587-92. PubMed ID: 16621599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of counselling for pregnant women exposed to potentially hazardous environmental factors.
    Czeizel A; Métneki J
    Acta Paediatr Hung; 1985; 26(3):175-85. PubMed ID: 4084408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic and gynecologic prevention of congenital developmental disorders].
    Cervenka J; Kapras J; Kovarik J; Bráza J
    Zentralbl Gynakol; 1976; 98(12):714-20. PubMed ID: 134606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal diagnosis. I: Prenatal diagnosis program at the Medical Genetics Unit of the Universidad de Zulia, Maracaibo, Venezuela].
    Prieto-Carrasquero M; Molero A; Carrasquero N; Paz V; González S; Pineda-Del Villar L; Del Villar A; Rojas-Atencio A; Quintero M; Fulcado W; Mena R; Morales-Machin A
    Invest Clin; 1998 Jun; 39(2):97-116. PubMed ID: 9707921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in socio-economic status, service utilization, and pregnancy outcomes between teenage and adult mothers.
    Isaranurug S; Mo-Suwan L; Choprapawon C
    J Med Assoc Thai; 2006 Feb; 89(2):145-51. PubMed ID: 16578999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Counseling before and during pregnancy. 1: Genetic counseling, risk of maternal age].
    Hertwig K; Dudenhausen JW
    MMW Fortschr Med; 1999 Oct; 141(43):43-4. PubMed ID: 10912122
    [No Abstract]   [Full Text] [Related]  

  • 12. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects.
    Dolan SM; Moore C
    Pediatrics; 2007 Sep; 120 Suppl 2():S66-70. PubMed ID: 17767007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of drug use in pregnancy: prevention of birth defects.
    Peters PW
    Ann Ist Super Sanita; 1993; 29(1):131-7. PubMed ID: 8129259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection and analysis of drug safety data in pregnancy.
    Moretti M
    Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic management of high-risk pregnancy].
    Vokaer A
    Rev Med Brux; 1983 Apr; 4(4):269-72. PubMed ID: 6878931
    [No Abstract]   [Full Text] [Related]  

  • 17. Prenatal diagnosis and genetic screening--integration into prenatal care.
    Rappaport VJ
    Obstet Gynecol Clin North Am; 2008 Sep; 35(3):435-58, ix. PubMed ID: 18760229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A statewide, toll-free telephone service to improve obstetric care.
    Rayburn WF; Crosby WM; Thurnau GR; Fishburne JI; Stanley JR; Coleman FH
    J Okla State Med Assoc; 1995 Aug; 88(8):342-4. PubMed ID: 7562143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of drug-induced congenital defects.
    De Santis M; Straface G; Carducci B; Cavaliere AF; De Santis L; Lucchese A; Merola AM; Caruso A
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):10-9. PubMed ID: 15474237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy in HIV-infected women. Counseling and care--12 years' experiences and results.
    Lindgren S; Ottenblad C; Bengtsson AB; Bohlin AB
    Acta Obstet Gynecol Scand; 1998 May; 77(5):532-41. PubMed ID: 9654176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.